Amalgam of Ternary Solid Dispersion and P-gp Efflux Inhibition in Development of Colon-targeted Tablets of Rifaximin

Manisha Lalan; Pranav Shah; Ruchita Kadam; Himan Patel

doi:10.4103/jrptps.JRPTPS_21_22

Outlines

Abstract
Copyright

https://doi.org/10.4103/jrptps.JRPTPS_21_22

Amalgam of Ternary Solid Dispersion and P-gp Efflux Inhibition in Development of Colon-targeted Tablets of Rifaximin

Author(s):

Manisha Lalan^1,*,

Pranav Shah²,

Ruchita Kadam¹,

Himan Patel¹

1Babaria Institute of Pharmacy, BITS Edu Campus, NH#8, P.O. Varnama, Vadodara, 391247 Gujarat, India

2Maliba Pharmacy College, Uka Tarsadia University, Maliba Campus, Gopal Vidyanagar, Bardoli-Mahuva Road, At & Po: Tarsadi 394350, Surat, Gujarat, India

Journal of Reports in Pharmaceutical Sciences:Vol. 11, issue 2; 222-35

Published online:Jun 23, 2022

Article type:Research Article

Received:Feb 08, 2022

Accepted:Aug 24, 2022

How to Cite:Manisha LalanPranav ShahRuchita KadamHiman PatelAmalgam of Ternary Solid Dispersion and P-gp Efflux Inhibition in Development of Colon-targeted Tablets of Rifaximin.J Rep Pharm Sci.11(2):e146249.https://doi.org/10.4103/jrptps.JRPTPS_21_22.

Abstract

Background: Rifaximin, a BCS class IV drug, possesses low bioavailability due to low solubility and low permeability attributable to P-gp efflux. The studies attempted to develop pH-sensitive rifaximin tablets based on ternary solid dispersion (TSD) for spatial and temporal drug release in colon.
Materials and Methods: Rifaximin TSD was prepared using Neusilin US2 as a mesoporous carrier and Poloxamer 188 as a hydrophilic carrier and P-gp inhibitor by solvent evaporation technique employing acetone at 1:5 ratio. The TSD was assessed for P-gp inhibition using the gut sac method and Caco-2 permeability studies. The TSD was compressed into tablets and coated with pH-sensitive polymers. Coating optimization was carried out using a 32 factorial design, wherein % coating and ratio of Eudragit S100:Eudragit L100 were the independent variables and % drug release at 2 h and % drug release at 8 h were the dependent variables.
Results: Differential scanning calorimetry, X-ray diffraction, and scanning electron microscopy studies of rifaximin TSD suggested amorphization of the drug. Gut sac studies indicated higher mucosal to serosal permeability of rifaximin from TSD. Caco-2 permeability studies demonstrated a 4.83-fold higher permeability of rifaximin from TSD (polaxamer 25% w/w and Neusilin 55% w/w of TSD) and a significant change in efflux ratio. Invitro release studies of the coated tablets displayed controlled and site-specific release at pH of the colon.
Conclusion: Effective, stable, pH-dependent rifaximin colon-targeted tablets with enhanced dissolution, permeability, and reduced P-gp efflux were developed. The achieved merits could translate into augmented bioavailability and dose reduction. Further in-vivo studies on this novel formulation, which is cost-effective and industrially scalable, can improve the pharmacoeconomics of inflammatory bowel disease management.

Keywords

solid dispersion adsorbate

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Manisha Lalan:[PubMed][Scholar]
Pranav Shah:[PubMed][Scholar]
Ruchita Kadam:[PubMed][Scholar]
Himan Patel:[PubMed][Scholar]